veliparib,pembrolizumab
merck,abbvie
[]
the long-term results of nrg-gi002 are being discussed as an oral presentation today by at #gi23. nrg-gi002 looked at using tnt in locally advanced rectal cancer. 
Advancing cancer research, improving lives.